Masahiro Tsuda

3PUBLICATIONS
27CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 31, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.

Akihito Kawazoe, Noboru Yamamoto, Naotoshi Sugimoto

|May 05, 2023
The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer.

Naoki Takegawa, Taku Hirabayashi, Shunta Tanaka

Pageof 1